跳至主要内容
临床试验/IRCT2014083014727N5
IRCT2014083014727N5已完成3 期

Comparison of the efficacy and safety of Salmeflo and Seretide in patients with asthma

Sadaf Darou Saba Company0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patients aged 18 years and older who are willing to participate and sign a consent form; Patients who have the ability of using the inhaler with correct technique;
  • exclusion criteria: Using of Inhaled Corticosteroid or Long Acting Beta Agonist in the last month before entering the study; patients with known hypersensitivity to Beta 2 agonist or Inhaled Corticosteroid; patients with lower respiratory system's infection (abnormal chest X ray) during the study; Alcoholics, drugs abuser; Patients who are pregnant or breastfeeding; Patients who use drug for another asthma trial; Patients with another severe and uncontrolled chronic disease, such as Heart failure, FC III, IV and history of myocardial infarction; Patients who show symptoms of acute reactions during the study; Non-compliance patient with treatment protocols; Requiring to use oxygen or systemic corticosteroid during the study; Disability to record the use of rescue medication accurately.

排除标准

  • 未提供

研究者

发起方
Sadaf Darou Saba Company

相似试验

已完成
不适用
Comparison of Clinical Effects of Salmeterol/Fluticasone Propionate Combination Products Delivered via Metered-Dose Inhaler with Dry Powder Inhaler in Patients with Moderate AsthmaBronchial asthma
JPRN-UMIN000009990ational Center for Global Health and Medicine40
尚未招募
3 期
A comparison of the efficacy and safety of 10% Salicylic and 10% urea cream in the treatment of childhood acanthosis nigricansAcanthosis nigricans&#44urea&#44salicylic acidAcanthosis nigricans
TCTR20201123003Faculty of Medicine, Srinakhariwirot University40
进行中(未招募)
不适用
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group study
EUCTR2007-005620-32-LTHEXAL AG472
进行中(未招募)
1 期
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group study
EUCTR2007-005620-32-PLHEXAL AG472
进行中(未招募)
不适用
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group studymoderate-to-severe persistent asthmaMedDRA version: 9.1Level: LLTClassification code 10003555Term: Asthma bronchial
EUCTR2007-005620-32-HUHEXAL AG472
Clinical safety and efficacy study in asthmatic... | 临床试验